Early potential safety signals for gliptins and gliflozins using real-world pharmacy data compared to spontaneous reporting.
- DOI
- 10.1371/journal.pone.0352399
- Published
- 2026-06-25
- Container
- PLoS One
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1371/journal.pone.0352399,
title = {Early potential safety signals for gliptins and gliflozins using real-world pharmacy data compared to spontaneous reporting.},
author = {Jimenez-Serrania MI and Martinez-Gonzalez SM and Herradon-Muñoz J and Treceño-Lobato C.},
year = {2026},
journal = {PLoS One},
doi = {10.1371/journal.pone.0352399},
url = {https://doi.org/10.1371/journal.pone.0352399}
}RIS
TY - JOUR TI - Early potential safety signals for gliptins and gliflozins using real-world pharmacy data compared to spontaneous reporting. AU - Jimenez-Serrania MI AU - Martinez-Gonzalez SM AU - Herradon-Muñoz J AU - Treceño-Lobato C. PY - 2026 JO - PLoS One DO - 10.1371/journal.pone.0352399 UR - https://doi.org/10.1371/journal.pone.0352399 ER -
APA
MI, J., SM, M., J, H., & C., T. (2026). Early potential safety signals for gliptins and gliflozins using real-world pharmacy data compared to spontaneous reporting.. PLoS One. https://doi.org/10.1371/journal.pone.0352399
Source records
- europe-pmc · retrieved 2026-09-26T11:04:48.295Z